FDA launches new priority review voucher program for select biopharmas

OsteoCool

Medtronic HQ
Biotech

Medtronic device gets FDA nod in metastatic bone tumors

Medtronic has secured FDA clearance to market its OsteoCool RF Ablation System as a palliative treatment for metastatic bone tumors.
Nick Paul Taylor Feb 15, 2017 9:36am